Sarah Pirikahu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah Pirikahu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Stone
School of Population and Global Health, University of Western Australia, Perth, WA, Australia
5 shared publications - Elizabeth Wylie
Department of Radiology Royal Perth Hospital Perth Western Australia Australia
3 shared publications - Catherine Woulfe
University of Western Australia
2 shared publications - Christobel Saunders
University of Melbourne Melbourne VIC
2 shared publications - David D. Sampson
Optical+Biomedical Engineering Laboratory, School of Electrical, Electronic & Computer Engineering, The University of Western Australia, 35 Stirling Highway, Perth, WA 6009, Australia
2 shared publications - Ellie Darcey
School of Public Health, Curtin University, Bentley, Western Australia, Australia
2 shared publications
Latest Publications
- Open Access
The Prospective Association between Early Life Growth and Breast Density in Young Adult Women
Breast density is a strong intermediate endpoint to investigate the association between early-life exposures and breast cancer risk. This study investigates the association between early-life growth and breast density in young adult women measured using Optical Breast Spectroscopy (OBS) and Dual X-ray Absorptiometry (DXA). OBS measurements were obtained for 536 female Raine Cohort Study participants at ages 27–28, with 268 completing DXA measurements. Participants with three or more height and weight measurements from ages 8 to 22 were used to generate linear growth curves for height, weight and body mass index (BMI) using SITAR modelling. Three growth parameters (size, velocity and timing) were examined for association with breast density measures, adjusting for potential confounders. Women who reached their peak height rapidly (velocity) and later in adolescence (timing) had lower OBS-breast density. Overall, women who were taller (size) had higher OBS-breast density. For weight, women who grew quickly (velocity) and later in adolescence (timing) had higher absolute DXA-breast density. Overall, weight (size) was also inversely associated with absolute DXA-breast density, as was BMI. These findings provide new evidence that adolescent growth is associated with breast density measures in young adult women, suggesting potential mediation pathways for breast cancer risk in later life.
Open AccessThe Prospective Association between Early Life Growth and Breast Density in Young Adult Women
Breast density is a strong intermediate endpoint to investigate the association between early-life exposures and breast cancer risk. This study investigates the association between early-life growth and breast density in young adult women measured using Optical Breast Spectroscopy (OBS) and Dual X-ray Absorptiometry (DXA). OBS measurements were obtained for 536 female Raine Cohort Study participants at ages 27–28, with 268 completing DXA measurements. Participants with three or more height and weight measurements from ages 8 to 22 were used to generate linear growth curves for height, weight and body mass index (BMI) using SITAR modelling. Three growth parameters (size, velocity and timing) were examined for association with breast density measures, adjusting for potential confounders. Women who reached their peak height rapidly (velocity) and later in adolescence (timing) had lower OBS-breast density. Overall, women who were taller (size) had higher OBS-breast density. For weight, women who grew quickly (velocity) and later in adolescence (timing) had higher absolute DXA-breast density. Overall, weight (size) was also inversely associated with absolute DXA-breast density, as was BMI. These findings provide new evidence that adolescent growth is associated with breast density measures in young adult women, suggesting potential mediation pathways for breast cancer risk in later life.
- Open Access
Characterizing the interactions between influenza and respiratory syncytial viruses and their implications for epidemic control
Pathogen-pathogen interactions represent a critical but little-understood feature of infectious disease dynamics. In particular, experimental evidence suggests that influenza virus and respiratory syncytial virus (RSV) compete with each other, such that infection with one confers temporary protection against the other. However, such interactions are challenging to study using common epidemiologic methods. Here, we use a mathematical modeling approach, in conjunction with detailed surveillance data from Hong Kong and Canada, to infer the strength and duration of the interaction between influenza and RSV. Based on our estimates, we further utilize our model to evaluate the potential conflicting effects of live attenuated influenza vaccines (LAIV) on RSV burden. We find evidence of a moderate to strong, negative, bidirectional interaction, such that infection with either virus yields 40-100% protection against infection with the other for one to five months. Assuming that LAIV reduces RSV susceptibility in a similar manner, we predict that the impact of such a vaccine at the population level would likely depend greatly on underlying viral circulation patterns. More broadly, we highlight the utility of mathematical models as a tool to characterize pathogen-pathogen interactions.
Open AccessCharacterizing the interactions between influenza and respiratory syncytial viruses and their implications for epidemic control
Pathogen-pathogen interactions represent a critical but little-understood feature of infectious disease dynamics. In particular, experimental evidence suggests that influenza virus and respiratory syncytial virus (RSV) compete with each other, such that infection with one confers temporary protection against the other. However, such interactions are challenging to study using common epidemiologic methods. Here, we use a mathematical modeling approach, in conjunction with detailed surveillance data from Hong Kong and Canada, to infer the strength and duration of the interaction between influenza and RSV. Based on our estimates, we further utilize our model to evaluate the potential conflicting effects of live attenuated influenza vaccines (LAIV) on RSV burden. We find evidence of a moderate to strong, negative, bidirectional interaction, such that infection with either virus yields 40-100% protection against infection with the other for one to five months. Assuming that LAIV reduces RSV susceptibility in a similar manner, we predict that the impact of such a vaccine at the population level would likely depend greatly on underlying viral circulation patterns. More broadly, we highlight the utility of mathematical models as a tool to characterize pathogen-pathogen interactions.
- 1 April 2022
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 93 (4) , 044101
Assessment of repeated reference measurements to inform the validity of optical breast spectroscopy
Mammographic breast density is a strong breast cancer risk factor, and its routine clinical measurement could potentially be used to identify women at higher risk of breast cancer and/or monitor primary prevention strategies. Previous reports of optical breast spectroscopy (OBS), a novel approach to measuring breast density, demonstrated that it is safe (no ionizing radiation), portable, low-cost, and does not require image interpretation but have been limited to small, single-center studies. Reference measurements taken on a phantom breast prior to and after each woman’s OBS assessment are required for the calibration of the system transfer function as a part of processing participant data. To inform the validity of participant data, a detailed description of the reference measurements and a repeatability analysis of these measurements taken before and after participant assessment is presented. Reference measurements for OBS from 539 women aged 18–40 years were obtained as a part of a high-throughput epidemiological pilot study. Of these, measurements from 20 women with no useable data due to device failure (3.7%) were excluded and from another 12 women due to user error. The intra-class correlation (ICC) within complete pairs of reference data (taken before and after assessment) was high (all ICC > 0.84). The analysis presented here confirms the OBS participant data as valid for use in ongoing epidemiological research, providing further supporting evidence of OBS as a measure of breast density. A novel method of measuring breast density is needed to bridge large gaps in the knowledge of breast density in younger women and its relation to later-life breast cancer risk.
- 1 April 2022
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 93 (4) , 044101
Assessment of repeated reference measurements to inform the validity of optical breast spectroscopy
Mammographic breast density is a strong breast cancer risk factor, and its routine clinical measurement could potentially be used to identify women at higher risk of breast cancer and/or monitor primary prevention strategies. Previous reports of optical breast spectroscopy (OBS), a novel approach to measuring breast density, demonstrated that it is safe (no ionizing radiation), portable, low-cost, and does not require image interpretation but have been limited to small, single-center studies. Reference measurements taken on a phantom breast prior to and after each woman’s OBS assessment are required for the calibration of the system transfer function as a part of processing participant data. To inform the validity of participant data, a detailed description of the reference measurements and a repeatability analysis of these measurements taken before and after participant assessment is presented. Reference measurements for OBS from 539 women aged 18–40 years were obtained as a part of a high-throughput epidemiological pilot study. Of these, measurements from 20 women with no useable data due to device failure (3.7%) were excluded and from another 12 women due to user error. The intra-class correlation (ICC) within complete pairs of reference data (taken before and after assessment) was high (all ICC > 0.84). The analysis presented here confirms the OBS participant data as valid for use in ongoing epidemiological research, providing further supporting evidence of OBS as a measure of breast density. A novel method of measuring breast density is needed to bridge large gaps in the knowledge of breast density in younger women and its relation to later-life breast cancer risk.
- 1 December 2021
- Published by Wiley in Australian & New Zealand Journal of Statistics
- Vol. 63 (4) , 639-657
Bayesian credible intervals for population attributable risk from case–control, cohort and cross‐sectional studies
Summary: Population attributable risk (PAR) and population attributable fraction (PAF) are used in epidemiology to predict the impact of removing a risk factor from the population. Until recently, no standard approach for calculating confidence intervals or the variance for PAR in particular was available in the literature. Previously we outlined a fully Bayesian approach to provide credible intervals for the PAR and PAF from a cross‐sectional study, where the data was presented in the form of a 2×2 table. However, extensions to cater for other frequently used study designs were not provided. In this paper we provide methodology to calculate credible intervals for the PAR and PAF for case–control and cohort studies. Additionally, we extend the cross‐sectional example to allow for the incorporation of uncertainty that arises when an imperfect diagnostic test is used. In all these situations the model becomes over‐parameterised, or non‐identifiable, which can result in standard ‘off‐the‐shelf’ Markov Chain Monte Carlo (MCMC) updaters taking a long time to converge or even failing altogether. We adapt an importance sampling methodology to overcome this problem, and propose some novel MCMC samplers that take into consideration the shape of the posterior ridge to aid in the convergence of the Markov chain.
- 1 December 2021
- Published by Wiley in Australian & New Zealand Journal of Statistics
- Vol. 63 (4) , 639-657
Bayesian credible intervals for population attributable risk from case–control, cohort and cross‐sectional studies
Summary: Population attributable risk (PAR) and population attributable fraction (PAF) are used in epidemiology to predict the impact of removing a risk factor from the population. Until recently, no standard approach for calculating confidence intervals or the variance for PAR in particular was available in the literature. Previously we outlined a fully Bayesian approach to provide credible intervals for the PAR and PAF from a cross‐sectional study, where the data was presented in the form of a 2×2 table. However, extensions to cater for other frequently used study designs were not provided. In this paper we provide methodology to calculate credible intervals for the PAR and PAF for case–control and cohort studies. Additionally, we extend the cross‐sectional example to allow for the incorporation of uncertainty that arises when an imperfect diagnostic test is used. In all these situations the model becomes over‐parameterised, or non‐identifiable, which can result in standard ‘off‐the‐shelf’ Markov Chain Monte Carlo (MCMC) updaters taking a long time to converge or even failing altogether. We adapt an importance sampling methodology to overcome this problem, and propose some novel MCMC samplers that take into consideration the shape of the posterior ridge to aid in the convergence of the Markov chain.
- 20 October 2021
- Published by Taylor & Francis in Climacteric
- Vol. 25 (2) , 147-154
Reproductive factors and breast arterial calcification: a systematic review and meta-analysis
Breast arterial calcification (BAC) is a common incidental finding on screening mammography. Recent evidence suggests that BAC is associated with cardiovascular disease (CVD). We systematically reviewed the associations between BAC and reproductive factors (menopausal status, hormone replacement therapy [HRT] use, oral contraceptive [OC] use and parity). MEDLINE and EMBASE databases, references of relevant papers and Web of Science were searched up to February 2020 for English-language studies that evaluated these associations. Study quality were determined and a random effects model was used to assess these associations. Nineteen observational studies (n = 47,249; three cohort studies, seven case–control studies, nine cross-sectional studies) were included. BAC was associated with menopause (nine studies; n = 15,870; odds ratio [OR] 2.67; 95% confidence interval [CI] 1.50–4.77) and parity (seven studies; n = 27,728; OR 2.50; 95% CI 1.68–3.71) and inversely with HRT use (10 studies; n = 33,156; OR 0.57; 95% CI 0.40–0.80). No association was found with OC use. Eleven studies were considered good in quality. Marked heterogeneity existed across all analyses. BAC is associated with HRT use, menopause and parity. However, careful interpretation is required as marked heterogeneity existed across all analyses. Traditional cardiovascular risk factors may need to be taken into account in future investigations of associations between BAC and reproductive factors. CRD42020141644.
- 20 October 2021
- Published by Taylor & Francis in Climacteric
- Vol. 25 (2) , 147-154
Reproductive factors and breast arterial calcification: a systematic review and meta-analysis
Breast arterial calcification (BAC) is a common incidental finding on screening mammography. Recent evidence suggests that BAC is associated with cardiovascular disease (CVD). We systematically reviewed the associations between BAC and reproductive factors (menopausal status, hormone replacement therapy [HRT] use, oral contraceptive [OC] use and parity). MEDLINE and EMBASE databases, references of relevant papers and Web of Science were searched up to February 2020 for English-language studies that evaluated these associations. Study quality were determined and a random effects model was used to assess these associations. Nineteen observational studies (n = 47,249; three cohort studies, seven case–control studies, nine cross-sectional studies) were included. BAC was associated with menopause (nine studies; n = 15,870; odds ratio [OR] 2.67; 95% confidence interval [CI] 1.50–4.77) and parity (seven studies; n = 27,728; OR 2.50; 95% CI 1.68–3.71) and inversely with HRT use (10 studies; n = 33,156; OR 0.57; 95% CI 0.40–0.80). No association was found with OC use. Eleven studies were considered good in quality. Marked heterogeneity existed across all analyses. BAC is associated with HRT use, menopause and parity. However, careful interpretation is required as marked heterogeneity existed across all analyses. Traditional cardiovascular risk factors may need to be taken into account in future investigations of associations between BAC and reproductive factors. CRD42020141644.
- 4 August 2020
- Published by Wiley in New Zealand Journal of Marine and Freshwater Research
- Vol. 55 (3) , 393-410
Correlations between environmental conditions and Vibrio parahaemolyticus or Vibrio vulnificus in Pacific oysters from New Zealand coastal waters
Vibrio parahaemolyticus and Vibrio vulnificus can be found in oysters in coastal environments. Vibrio vulnificus can induce life‐threatening illness when ingested with oysters, while V. parahaemolyticus usually causes self‐limiting gastroenteritis. This study investigated correlations between concentrations of these Vibrio species in Pacific oysters from eight New Zealand coastal regions (2008–2017), and seawater surface temperature (SST), salinity and rainfall. In the pooled data, most (88%) of the oyster samples were collected during summer and autumn. The prevalence of V. parahaemolyticus and V. vulnificus was 85% and 15%, respectively. Vibrio vulnificus was always detected in the presence of V. parahaemolyticus . Across all regions, V. parahaemolyticus concentration positively correlated with SST ( r S = 0.60), but not with salinity ( r S = −0.01). Vibrio vulnificus concentration weakly correlated with SST ( r S = 0.26) and salinity ( r S = −0.21). Linear and generalised additive models were investigated but none were satisfactory for prediction. Salinity and SST explained < 50% of the variability in V. parahaemolyticus concentrations, indicating that other environmental or biological factors contributed. When SST, salinity and rainfall 15 days prior to harvesting were investigated for one region, SST was the best pre‐harvest indicator for elevated concentrations of both Vibrio species.
- 4 August 2020
- Published by Wiley in New Zealand Journal of Marine and Freshwater Research
- Vol. 55 (3) , 393-410
Correlations between environmental conditions and Vibrio parahaemolyticus or Vibrio vulnificus in Pacific oysters from New Zealand coastal waters
Vibrio parahaemolyticus and Vibrio vulnificus can be found in oysters in coastal environments. Vibrio vulnificus can induce life‐threatening illness when ingested with oysters, while V. parahaemolyticus usually causes self‐limiting gastroenteritis. This study investigated correlations between concentrations of these Vibrio species in Pacific oysters from eight New Zealand coastal regions (2008–2017), and seawater surface temperature (SST), salinity and rainfall. In the pooled data, most (88%) of the oyster samples were collected during summer and autumn. The prevalence of V. parahaemolyticus and V. vulnificus was 85% and 15%, respectively. Vibrio vulnificus was always detected in the presence of V. parahaemolyticus . Across all regions, V. parahaemolyticus concentration positively correlated with SST ( r S = 0.60), but not with salinity ( r S = −0.01). Vibrio vulnificus concentration weakly correlated with SST ( r S = 0.26) and salinity ( r S = −0.21). Linear and generalised additive models were investigated but none were satisfactory for prediction. Salinity and SST explained < 50% of the variability in V. parahaemolyticus concentrations, indicating that other environmental or biological factors contributed. When SST, salinity and rainfall 15 days prior to harvesting were investigated for one region, SST was the best pre‐harvest indicator for elevated concentrations of both Vibrio species.
- Open Access
What do women know about breast density? A public screening program perspective
Background: This study assesses knowledge of breast density, one of breast cancer’s strongest risk factors, in women attending a public mammographic screening program in Western Australia that routinely notifies women if they have dense breasts. Methods: Survey data was collected from women who were notified they have dense breasts and women who had not (controls). Descriptive data analysis was used to summarize responses. Results: Of the 6183 women surveyed, over 85% of notified women knew that breast density makes it difficult to see cancer on a mammogram (53.9% in controls). A quarter of notified women knew that having dense breasts puts women at increased risk for breast cancer (13.2% in controls). Overall, 50.1% of notified women indicated that they thought the amount of information provided was “just right” and 24.9% thought it was “too little”, particularly women notified for the first time (32.1%). Conclusion: The main message of reduced sensitivity of mammography in women with dense breasts provided by the screening program appears to be getting though. However, women are largely unaware that increased breast density is associated with increased risk. Women notified of having dense breasts for the first time could potentially benefit from additional information.
Open AccessWhat do women know about breast density? A public screening program perspective
Background: This study assesses knowledge of breast density, one of breast cancer’s strongest risk factors, in women attending a public mammographic screening program in Western Australia that routinely notifies women if they have dense breasts. Methods: Survey data was collected from women who were notified they have dense breasts and women who had not (controls). Descriptive data analysis was used to summarize responses. Results: Of the 6183 women surveyed, over 85% of notified women knew that breast density makes it difficult to see cancer on a mammogram (53.9% in controls). A quarter of notified women knew that having dense breasts puts women at increased risk for breast cancer (13.2% in controls). Overall, 50.1% of notified women indicated that they thought the amount of information provided was “just right” and 24.9% thought it was “too little”, particularly women notified for the first time (32.1%). Conclusion: The main message of reduced sensitivity of mammography in women with dense breasts provided by the screening program appears to be getting though. However, women are largely unaware that increased breast density is associated with increased risk. Women notified of having dense breasts for the first time could potentially benefit from additional information.
- Open Access
- 30 March 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4) , 955
Confusion and Anxiety Following Breast Density Notification: Fact or Fiction?
In the absence of evidence-based screening recommendations for women with dense breasts, it is important to know if breast density notification increases women’s anxiety. This study describes psychological reactions and future screening intentions of women attending a public mammographic screening program in Western Australia. Two-thirds of notified women indicated that knowing their breast density made them feel informed, 21% described feeling anxious, and 23% confused. Of the notified women who reported anxiety, 96% intended to re-screen when due (compared to 91% of all notified women and 93% of controls; p = 0.007 and p < 0.001, respectively). In summary, reported anxiety (following breast density notification) appears to increase women’s intentions for future screening, not the reverse.
- 30 March 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (4) , 955
Open AccessConfusion and Anxiety Following Breast Density Notification: Fact or Fiction?
In the absence of evidence-based screening recommendations for women with dense breasts, it is important to know if breast density notification increases women’s anxiety. This study describes psychological reactions and future screening intentions of women attending a public mammographic screening program in Western Australia. Two-thirds of notified women indicated that knowing their breast density made them feel informed, 21% described feeling anxious, and 23% confused. Of the notified women who reported anxiety, 96% intended to re-screen when due (compared to 91% of all notified women and 93% of controls; p = 0.007 and p < 0.001, respectively). In summary, reported anxiety (following breast density notification) appears to increase women’s intentions for future screening, not the reverse.